News
21h
Medpage Today on MSNAnti-Endothelin Devices Show Promise in Diabetic Eye Disease
In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...
EHR-Based Survival Models Accurately Predict Progression to Proliferative Diabetic Retinopathy: JAMA
USA: A new study has found that survival models using electronic health record (EHR) data can accurately predict the ...
Statistical analysis showed a strong association between advanced diabetic retinopathy and an increased likelihood of heart ...
For example, mesangial proliferative glomerulonephritis, diffuse proliferative glomerulonephritis, crescentic glomerulonephritis, and a sclerosing glomerulopathy can be present in both C3GN and ...
Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...
The role of genomic instability and proliferative activity for development of distant metastases in breast cancer was analysed, and the relative contribution of these two risk factors was ...
WAIKOLOA, Hawaii — Katherine E. Talcott, MD, gave an overview on managing vitreous hemorrhage in proliferative diabetic retinopathy at Retina 2022.Talcott said that performing surgery for ...
Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with ...
The broad histologic classifications included nonproliferative disease in 6061 (66.7 percent), proliferative disease without atypia in 2690 (29.6 percent), and atypical hyperplasia in 336 (3.7 ...
FORT LAUDERDALE, Fla. — Early pars plana vitrectomy may be a low-cost, definitive treatment for patients with proliferative diabetic retinopathy, according to a speaker at the Retina World Congress.
The proliferative ability of the tumor was investigated by Ki-67 monoclonal antibody (clone MIB-1; Dako, Glostrup, Denmark) immunohistochemically, which were performed in a standard avidin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results